跳至主要内容
临床试验/NCT01659307
NCT01659307已完成2 期

The Effect of Aspirin on REducing iNflammation in Human in Vivo Model of Acute Lung Injury

Belfast Health and Social Care Trust1 个研究点 分布在 1 个国家目标入组 33 人开始时间: 2012年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
33
试验地点
1
主要终点
Bronchoalveolar lavage IL-8 concentration

研究概览

简要总结

This is a double-blind, placebo-controled, randomized trial to investigate if aspirin pre-treatment has anti-inflammatory effects in a model of acute lung injury induced by inhaled endotoxin (LPS) in healthy human volunteers.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy subjects

排除标准

  • Age < 18 years
  • Pregnancy or breast feeding or woman of childbearing potential not using
  • adequate contraception.
  • Participation in a clinical trial of an investigational medicinal product within 30 days
  • Consent declined Aspirin or non steroidal anti-inflammatory (NSAID) use in the past 4 weeks
  • History of asthma
  • Known aspirin or NSAID hypersensitivity
  • History of peptic ulcer disease
  • Platelet count < 150 x 106/ml
  • Aspirin resistance

研究组 & 干预措施

Aspirin 75mg

Active Comparator

Aspirin 75mg once daily for 7 days. Administered by mouth.

干预措施: Aspirin 75mg (Drug)

Aspirin 1200mg

Active Comparator

Asprin 600mg twice daily for 7 days. Administered by mouth.

干预措施: Aspirin 1200mg (Drug)

Lactose powder

Placebo Comparator

Placebo for 7 days. Administered by mouth.

干预措施: Lactose powder (Drug)

结局指标

主要结局

Bronchoalveolar lavage IL-8 concentration

时间窗: 6 hrs after LPS inhalation

次要结局

  • Plasma inflammatory response biomarkers(6 and 24 hrs after LPS inhalation)
  • Alveolar inflammatory response biomarkers(6 hrs after LPS inhalation)
  • Alveolar epithelial and endothelial function and injury biomarkers(6 hrs after LPS inhalation)
  • Lipid inflammatory mediators(6 and 24 hrs after LPS inhalation)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Professor Danny McAuley

Professor of Intensive care Medicine

Belfast Health and Social Care Trust

研究点 (1)

Loading locations...

相似试验